John Waddell, Business Development Director – Pharma, PDI Contract Manufacturing10.20.20
Wet wipes and other pre-moistened applicators for topical drug administration are becoming more prevalent in drug development. These formats offer patient and provider-friendly life cycle management opportunities for topical drug manufacturers. Demand for wipes used in healthcare settings is expected to increase through 2023 and demand for all types of wipes is forecast to expand even greater. The Covid-19 pandemic has made these forecasts obsolete and points to unforeseen demand.
Patient preference and convenience are two key growth drivers for wet wipes in drug development. Recent market research conducted by AYTM market research concluded that two out of three patients prefer wet wipes to traditional topical creams, ointments, lotions, or gels. The majority of all patients agreed with all of the following statements:
• Wipes allow for more targeted, localized drug delivery with less potential for side effects;
• Individual packages for ea
FREE SUBSCRIPTION
Continue reading this story and get 24/7 access to Nonwovens Industry for FREE
FREE SUBSCRIPTION
